The higher degree values of AKT1, TP53, ESR1, and MYC make them promising potential targets for LMQXM in the treatment of ADHD, but no studies have clearly shown their relevance to the pathogenesis of ADHD. This evidence concerns the gene AKT1 and attention deficit-hyperactivity disorder.